Immuni T
↗Montreal, Canada
Immuni T is a specialized Contract Research Organization (CRO) based in Montreal, Canada, established in 2006. The company focuses on providing high-quality research and development services to support the discovery, pre-clinical, and clinical efforts of global biotech and pharmaceutical companies.
Their expertise lies in immunology, offering a wide range of services including customized cell-based assays, flow cytometry, ELISA assays, and human ex-vivo immunogenicity prediction. They operate a certified, state-of-the-art facility and maintain strong collaborative partnerships with major universities and hospitals in Montreal to facilitate advanced research.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2006
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Biotherapeutics, Biosimilars, Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Concordia University, McGill University, Université de Montréal, Université du Québec à Montréal
COMPETITION
Position:Niche Player
Competitors:360biolabs, Other specialized immunology CROs
LEADERSHIP
Key Executives:
Luc Villeneuve - Ph.D., Executive
LINKS
Website:immunit.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Immuni T and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immuni T. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.